Takeaway

• The study of tumour heterogeneity explains why some cancers are especially aggressive and resistant to treatment.
• Knowledge of tumour biology and clinical trial optimization will help to reduce hard-to-treat cancer mortality.

“Why is cancer the emperor of all maladies? One of the key answers is because cancer development is...